Add To My Watchlist

Overall Rating: 91 Strong Bullish

Action to take: BUY
Strong Bullish stocks are expected to outperform the market by 3X over the next 12 months.
91
Priced Based
Momentum
87
Size
8
Volatility
91
Fundamental Based
Value
41
Quality
99
Growth
98
Positive Factors (Top 20%)
Momentum: Strong-momentum stocks tend to outperform weak-momentum stocks.
Volatility: Low-volatility stocks tends to outperform high-volatility stocks.
Quality: High-quality stocks tend to outperform low-quality stocks.
Growth: High-growth stocks tend to outperform low-growth stocks.
Negative Factors (Bottom 20%)
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Collapse Detail

Latest Insights on REGN

biopharma stock DVAX High-Quality Pharma Stock Captures Powerful Biotech Mega Trend Among the most lucrative mega trends of the next decade, biotech is poised to grow revenues 77% by 2026. This Power Stock has been on the front lines of the battle against COVID-19 and rates a 96 on our proprietary system.
The Great Pig Proxy Fight Of 2022: Carl Icahn Challenges McDonald’s Over Treatment Of Pigs
by Money Moves February 23, 2022 Money Moves
Carl Icahn, world-renowned investor—and apparently an avid animal lover—is threatening McDonald's over its treatment of the pigs used by its suppliers.
biotech stock to buy SIGA Technologies biotech REIT biotech value investor Be a Biotech Value Investor (Start With 2 Stocks!)
by Adam O'Dell February 21, 2022 Investing
Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in tech sectors.
earnings Rambus Enterprise Products Partners american eagle abercrombie MTN MRVL lzb swbi AYI MU PSMT AZZ BLK PEP TXN JNJ GILD TER CSCO AMAT Chewy Toll Brothers Expedia Fiserv RYAN CWC CALM LAKE Earnings mtdr Target TGT Walmart WMT 2 Stocks Set for Massive Post-Earnings Moves (FISV & EXPE Analysis)
by Chad Shoop February 6, 2022 Investing
In this week's Earnings Edge: Fiserv Inc. (Nasdaq: FISV) and Expedia Group Inc. (Nasdaq: EXPE) could head in different directions post-call.
SIRI stock SIRI, REGN Earnings: A Prime Candidate for Options Straddle
by Chad Shoop January 30, 2022 Investing
Regeneron Pharmaceuticals (Nasdaq: REGN) and Sirius XM Holdings (Nasdaq: SIRI) stocks are set to break out. Keep an eye on earnings.